INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 202 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $304,946 | -79.2% | 16,448 | -84.9% | 0.01% | -80.0% |
| Q1 2023 | $1,464,918 | +20.8% | 109,078 | +11.3% | 0.04% | +17.6% |
| Q4 2022 | $1,212,272 | -13.0% | 98,001 | -1.9% | 0.03% | -30.6% |
| Q3 2022 | $1,393,000 | +67.8% | 99,852 | +66.1% | 0.05% | +32.4% |
| Q2 2022 | $830,000 | +60.5% | 60,121 | +72.6% | 0.04% | -9.8% |
| Q3 2021 | $517,000 | -17.0% | 34,839 | +29.0% | 0.04% | -28.1% |
| Q1 2021 | $623,000 | -13.6% | 27,004 | +55.3% | 0.06% | +23.9% |
| Q3 2020 | $721,000 | +7.6% | 17,387 | +63.4% | 0.05% | -6.1% |
| Q1 2020 | $670,000 | +9.5% | 10,640 | +15.3% | 0.05% | -7.5% |
| Q3 2019 | $612,000 | -53.6% | 9,227 | -44.3% | 0.05% | -55.5% |
| Q2 2019 | $1,319,000 | -53.8% | 16,576 | -35.0% | 0.12% | -41.4% |
| Q1 2019 | $2,853,000 | +134.8% | 25,509 | +111.5% | 0.20% | +167.1% |
| Q4 2018 | $1,215,000 | -47.0% | 12,059 | -67.6% | 0.08% | -52.5% |
| Q1 2018 | $2,291,000 | +120.9% | 37,238 | +491.1% | 0.16% | -31.0% |
| Q3 2016 | $1,037,000 | -7.5% | 6,300 | -27.8% | 0.23% | +77.1% |
| Q1 2016 | $1,121,000 | -47.6% | 8,729 | -32.3% | 0.13% | -28.8% |
| Q3 2015 | $2,139,000 | +67.2% | 12,900 | +143.4% | 0.18% | +27.8% |
| Q2 2015 | $1,279,000 | -6.8% | 5,300 | -39.8% | 0.14% | -40.7% |
| Q4 2014 | $1,372,000 | – | 8,800 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |